BWX Technologies (BWXT) Expected to Announce Earnings on Monday

BWX Technologies (NYSE:BWXT) is expected to be announcing its Q4 2025 results after the market closes on Monday, February 23rd. Analysts expect the company to announce earnings of $0.91 per share and revenue of $837.4680 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Monday, February 23, 2026 at 5:00 PM ET.

BWX Technologies Price Performance

BWXT opened at $200.31 on Monday. The stock has a fifty day moving average price of $192.65 and a 200 day moving average price of $185.22. The company has a current ratio of 1.71, a quick ratio of 1.62 and a debt-to-equity ratio of 1.21. BWX Technologies has a 1 year low of $84.21 and a 1 year high of $220.57. The stock has a market cap of $18.31 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 3.22 and a beta of 0.83.

Analyst Ratings Changes

BWXT has been the subject of several research reports. Northland Securities set a $225.00 price target on BWX Technologies in a report on Tuesday, November 4th. Wall Street Zen raised shares of BWX Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Zacks Research raised shares of BWX Technologies from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 21st. Weiss Ratings lowered shares of BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 26th. Finally, CJS Securities upgraded shares of BWX Technologies to a “strong-buy” rating in a report on Friday, December 12th. Three equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, BWX Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $199.20.

Insider Buying and Selling at BWX Technologies

In related news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $203.26, for a total value of $2,032,600.00. Following the transaction, the chief executive officer directly owned 177,594 shares in the company, valued at approximately $36,097,756.44. This trade represents a 5.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.47% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of BWXT. FORA Capital LLC acquired a new stake in shares of BWX Technologies in the fourth quarter valued at about $2,081,000. Kestra Advisory Services LLC grew its holdings in BWX Technologies by 13.1% in the 4th quarter. Kestra Advisory Services LLC now owns 4,217 shares of the technology company’s stock valued at $729,000 after buying an additional 489 shares during the last quarter. CreativeOne Wealth LLC bought a new position in BWX Technologies in the 4th quarter worth approximately $416,000. Parkside Financial Bank & Trust increased its position in BWX Technologies by 45.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 702 shares of the technology company’s stock worth $121,000 after buying an additional 219 shares during the period. Finally, Marshall Wace LLP acquired a new position in shares of BWX Technologies during the fourth quarter worth approximately $9,203,000. Institutional investors and hedge funds own 94.39% of the company’s stock.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.